Cargando…
Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes
AIMS/INTRODUCTION: To investigate the effect of pitavastatin on glucose control in patients with type 2 diabetes. MATERIALS AND METHODS: Medical records of 340 patients with type 2 diabetes treated with pitavastatin or atorvastatin between 1 August 2013 and 31 May 2014 were reviewed. A total of 96 p...
Autores principales: | Huang, Chung‐Huei, Huang, Yu‐Yao, Hsu, Brend Ray‐Sea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009141/ https://www.ncbi.nlm.nih.gov/pubmed/27181110 http://dx.doi.org/10.1111/jdi.12483 |
Ejemplares similares
-
A short-term follow-up of glycemic and body weight changes in diabetic patients who replaced dipeptidyl peptidase-4 inhibitors with the sodium-glucose cotransporter 2 inhibitor empagliflozin
por: Huang, Chung-Huei, et al.
Publicado: (2018) -
GLP-1 receptor agonist exenatide restores atypical antipsychotic clozapine treatment-associated glucose dysregulation and damage of pancreatic islet beta cells in mice
por: Hsu, Brend Ray-Sea, et al.
Publicado: (2016) -
Synergistic Effect of Hyperglycemia and p27(kip1)
Suppression on Adult Mouse Islet Beta Cell Replication
por: Chen, Szu-Tah, et al.
Publicado: (2012) -
Glycated albumin is correlated with glycated hemoglobin in type 2 diabetes
por: Ciobanu, Dana Mihaela, et al.
Publicado: (2019) -
Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment
por: Hsu, Brend Ray-Sea, et al.
Publicado: (2017)